Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018 –2020

Volume 19, Issue 3, December 2023 .

Source: Human Vaccines and Immunotherapeutics - December 1, 2023 Category: Allergy & Immunology Authors: Qianhui WuMengcen QianSarah WelbyAdrienne GuignardDominique RosillonKusuma GopalaYuan XuKeruo LiuYunkun HeNing JiangQin TanJiamin XieTaoying ZhuQizhang WangYingzi PanRuikun ZengJie YangXiaoqian ZhaoMan ZhouAdoraci ón Navarro-TornéHongjie YuDorota Borysa Source Type: research